MicroRNA MIR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Schwickert, Alexander ^a   Weghake, Esther ^a   Brüggemann, Kathrin ^a   Engbers, Annika ^a   Brinkmann, Benjamin F ^b   Kemper, Björn ^b   Seggewiß, Jochen ^c   Stock, Christian ^b,d   Ebnet, Klaus ^b   Kiesel, Ludwig ^a   Riethmüller, Christoph ^e   Götte, Martin ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c INST OF REPRO MED OF THE UNIV   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e Serend ip GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENYLATE CYCLASE; ADENYLATE CYCLASE 9; CD51 ANTIGEN; COFILIN 2; INTERLEUKIN 6 RECEPTOR; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; MICRORNA; MICRORNA 142 3P; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MEMBRANE COMPONENT TYPE 2; RAC1 PROTEIN; RHO KINASE; RHO KINASE 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN; 3' UNTRANSLATED REGION; MIRN142 MICRORNA, HUMAN; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; WASL PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; ATOMIC FORCE MICROSCOPY; BREAST CANCER; BREAST CARCINOGENESIS; CELL MOTILITY; CELL SIZE; CELL VOLUME; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIGITAL HOLOGRAPHIC MICROSCOPY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LUCIFERASE ASSAY; MICROSCOPY; PHENOTYPE; PROTEIN LOCALIZATION; TUMOR INVASION; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CYTOSKELETON; FEMALE; GENETICS; MCF-7 CELL LINE; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ACTINS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SIZE; CYTOSKELETON; DOWN-REGULATION; FEMALE; HUMANS; INTEGRIN ALPHAV; MCF-7 CELLS; MICRORNAS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL;

EID: 84955584515     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143993     Document Type: Article

References (72)

1. Hutvágner G, McLachlan J, Pasquinelli AE, Bálint E, Tuschl T, Zamore PD. (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838. PMID: 11452083
2. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. (2007) DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet. 39: 380-385. PMID: 17259983
3. Ibrahim SA, Hassan H, Götte M.(2014) MicroRNA regulation of proteoglycan function in cancer. FEBS J. 281:5009-5022. doi: 10.1111/febs.13026 PMID: 25168226
4. Doench JG, Sharp PA. (2004) Specificity of microRNA target selection in translational repression. Genes Dev. 18:504-511. PMID: 15014042
5. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. (2005) MicroRNA Gene Expression Deregulation in Human Breast Cancer. Cancer Res. 65: 7065-7070. PMID: 16103053
6. Ma L, Teruya-Feldstein J, Weinberg RA. (2007) Tumour invasion and metastasis initiated by micro- RNA-10b in breast cancer. Nature 449: 682-688. PMID: 17898713
7. Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, et al. (2009) MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J. Pathol. 219: 214-221. doi: 10.1002/ path.2586 PMID: 19593777
8. Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, et al. (2012) Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci U S A 109: 3024-3029. doi: 10.1073/pnas.1200010109 PMID: 22315424
9. Götte M, Mohr C, Koo CY, Stock C, Vaske AK, Viola M, et al. (2010) miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene 29: 6569-6580. doi: 10.1038/onc.2010.386 PMID: 20818426
10. Ibrahim SA, Yip GW, Stock C, Pan JW, Neubauer C, Poeter M, et al. (2012) Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and Ecadherin- dependent mechanism. Int. J. Cancer 131: E884-96. doi: 10.1002/ijc.27629 PMID: 22573479
11. Janssen EAM, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, Søiland H, et al. (2010) Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Mod. Pathol. 23: 1567-1576. doi: 10.1038/modpathol.2010.177 PMID: 20818337
12. Bissels U, Wild S, Tomiuk S, Hafner M, Scheel H, Mihailovic A, et al. (2011) Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells. Stem Cells 29: 847-857. doi: 10.1002/stem.627 PMID: 21394831
13. Huang B, Zhao J, Lei Z, Shen S, Li D, Shen GX, et al. (2009) miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep. 10: 180-185. doi: 10.1038/embor.2008.224 PMID: 19098714
14. Flamant S, Ritchie W, Guilhot J, Holst J, Bonnet ML, Chomel JC, et al. (2010) Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica, 95: 1325-1333. doi: 10. 3324/haematol.2009.020636 PMID: 20460641
15. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, Delisi C, et al. (2010) Identification of a MicroRNA Panel for Clear-cell Kidney Cancer. Urology 75: 835-841. doi: 10.1016/j.urology.2009.10.033 PMID: 20035975
16. Wu L, Cai C, Wang X, Liu M, Li X, Tang H. (2011) MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett. 585: 1322-1330. doi: 10.1016/j.febslet.2011.03.067 PMID: 21482222
17. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjøt L, et al. (2008) Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer. Cancer Res. 68: 6416-6424. doi: 10. 1158/0008-5472.CAN-07-6110 PMID: 18676867
18. Marini F, Luzi E, Brandi ML. (2011) MicroRNA Role in Thyroid Cancer Development. J. Thyroid Res. 2011: 407123. doi: 10.4061/2011/407123 PMID: 21687652
19. Brooks PC, Strömblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. (1995) Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96: 1815-1822. PMID: 7560073
20. Chen Q, Manning CD, Millar H, McCabe FL, Ferrante C, Sharp C, et al. (2008) CNTO 95, a fully human anti alphav integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells. Clin. Exp. Metastasis 25: 139-148. PMID: 18064530
21. Wu YJ, Muldoon LL, Gahramanov S, Kraemer DF, Marshall DJ, Neuwelt EA. (2012) Targeting αVintegrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model. J. Neurooncol. 110: 27-36. doi: 10.1007/s11060-012-0942-0 PMID: 22842979
22. Lacroix M, Leclercq G. (2004) Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update. Breast Cancer Res. Treat. 83: 249-289. PMID: 14758095
23. Seidler DG, Faiyaz-Ul-Haque M, Hansen U, Yip GW, Zaidi SH, Teebi AS, et al. (2006) Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7). J. Mol. Med. (Berl). 84:583-594. PMID: 16583246
24. Kemper B, Carl D, Schnekenburger J, Bredebusch I, Schäfer M, DomschkeW, et al. (2006) Investigation of living pancreas tumor cells by digital holographic microscopy. J. Biomed. Opt. 11: 34005. PMID: 16822055
25. Kemper B, Kosmeier S, Langehanenberg P, von Bally G, Bredebusch I, DomschkeW, et al. (2007) Integral refractive index determination of living suspension cells by multifocus digital holographic phase contrast microscopy. J. Biomed. Opt. 12: 054009. PMID: 17994897
26. Bettenworth D, Lenz P, Krausewitz P, Brückner M, Ketelhut S, Domagk D, et al. (2014) Quantitative stain-free and continuous multimodal monitoring of wound healing in vitro with digital holographic microscopy. PLoS One. 9:e107317. doi: 10.1371/journal.pone.0107317 PMID: 25251440
27. Riethmüller C, Jungmann P, Wegener J, Oberleithner H. (2006) Bradykinin shifts endothelial fluid passage from para- to transcellular routes. Pflugers Arch. 453: 157-165. PMID: 17047985
28. Thoelking G, Reiss B, Wegener J, Oberleithner H, Pavenstaedt H, Riethmuller C. (2010) Nanotopography follows force in TGF-beta1 stimulated epithelium. Nanotechnology 21: 265102. doi: 10.1088/0957- 4484/21/26/265102 PMID: 20522928
29. Pollari S, Leivonen SK, Perälä M, Fey V, Käkönen SM, Kallioniemi O. (2012) Identification of micro- RNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells. PLoS ONE 7: e37361. doi: 10.1371/journal.pone.0037361 PMID: 22629385
30. Tanic M, Yanowski K, Gómez-López G, Rodriguez-Pinilla MS, Marquez-Rodas I, Osorio A, et al. (2015) MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors. Int. J. Cancer 136:593-602. doi: 10.1002/ ijc.29021 PMID: 24917463
31. Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, et al. (2006) BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res. 66:41-45. PMID: 16397213
32. Holliday DL, Speirs V. (2011) Choosing the right cell line for breast cancer research.Breast Cancer Res. 13:215. doi: 10.1186/bcr2889 PMID: 21884641
33. Betel D, Wilson M, Gabow A, Marks DS, Sander C. (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res. 36: D149-153. PMID: 18158296
34. Kovacs EM, Verma S, Ali RG, Ratheesh A, Hamilton NA, Akhmanova A, et al. (2011) NWASP regulates the epithelial junctional actin cytoskeleton through a non-canonical postnucleation pathway. Nat. Cell Biol. 13: 934-943. doi: 10.1038/ncb2290 PMID: 21785420
35. Mogilner A, Oster G. (2003) Force generation by actin polymerization II: the elastic ratchet and tethered filaments. Biophys. J. 84: 1591-1605. PMID: 12609863
36. Desmarais V, Yamaguchi H, Oser M, Soon L, Mouneimne G, Sarmiento C, et al. (2009) N-WASP and cortactin are involved in invadopodium-dependent chemotaxis to EGF in breast tumor cells. Cell Motil. Cytoskeleton 66: 303-316. doi: 10.1002/cm.20361 PMID: 19373774
37. Bischoff A, Huck B, Keller B, Strotbek M, Schmid S, Boerries M, et al. (2014) miR149 functions as a tumor suppressor by controlling breast epithelial cell migration and invasion. Cancer Res. 74:5256-5265. doi: 10.1158/0008-5472.CAN-13-3319 PMID: 25035394
38. Luo D, Wilson JM, Harvel N, Liu J, Pei L, Huang S, et al. (2013) A systematic evaluation of miRNA: mRNA interactions involved in the migration and invasion of breast cancer cells. J. Transl. Med. 11:57 doi: 10.1186/1479-5876-11-57 PMID: 23497265
39. Wong CC, Wong CM, Tung EK, Man K, Ng IO. (2009) Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology. 49:1583-1594. doi: 10.1002/ hep.22836 PMID: 19205033
40. Kästingsschäfer CS, Schäfer SD, Kiesel L, Götte M. (2015) miR-142-3p is a novel regulator of cell viability and proinflammatory signalling in endometrial stroma cells. Reprod. Biomed. Online. 30:553-556. doi: 10.1016/j.rbmo.2015.01.002 PMID: 25754227
41. Yu F, Shi Y, Wang J, Li J, Fan D, Ai W. (2013) Deficiency of kruppel-like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid-derived suppressor cells. Int. J. Cancer 133:2872-2883. doi: 10.1002/ijc.28302 PMID: 23737434
42. Albrecht C, Huck V, Wehling M, Wendler A. (2012) In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1. Steroids 77:1543-1550. doi: 10.1016/j.steroids.2012.09.006 PMID: 23064006
43. Meyer T, Marshall JF, Hart IR. (1998) Expression of alphav integrins and vitronectin receptor identity in breast cancer cells. Br J Cancer. 77:530-536. PMID: 9484807
44. Nusblat LM, Dovas A, Cox D. (2011) The non-redundant role of N-WASP in podosome-mediated matrix degradation in macrophages. Eur. J. Cell Biol. 90:205-212 doi: 10.1016/j.ejcb.2010.07.012 PMID: 20732727
45. Sanchez AM, Flamini MI, Baldacci C, Goglia L, Genazzani AR, Simoncini T. (2010) Estrogen receptoralpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol. Endocrinol. 24:2114-2125 doi: 10.1210/me.2010-0252 PMID: 20880986
46. Takahashi K, Suzuki K. (2011) WAVE2, N-WASP, and Mena facilitate cell invasion via phosphatidylinositol 3-kinase-dependent local accumulation of actin filaments. J. Cell. Biochem. 112:3421-3429. doi: 10.1002/jcb.23276 PMID: 21769917
47. Kimura F, Iwaya K, Kawaguchi T, Kaise H, Yamada K, Mukai K, et al. (2010) Epidermal growth factordependent enhancement of invasiveness of squamous cell carcinoma of the breast. Cancer Sci. 101:1133-1140. doi: 10.1111/j.1349-7006.2010.01527.x PMID: 20219074
48. Giri A, Bajpai S, Trenton N, Jayatilaka H, Longmore GD, Wirtz D. (2013) The Arp2/3 complex mediates multigeneration dendritic protrusions for efficient 3-dimensional cancer cell migration. FASEB J. 27: 4089-4099. doi: 10.1096/fj.12-224352 PMID: 23796785
49. Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, et al. (2005) Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J. Cell Biol. 168: 441-452. PMID: 15684033
50. Gligorijevic B, Wyckoff J, Yamaguchi H, Wang Y, Roussos ET, Condeelis J. (2012) N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J. Cell Sci. 125: 724-734. doi: 10.1242/jcs.092726 PMID: 22389406
51. Sturge J, Hamelin J, Jones GE. (2002) N-WASP activation by a beta1-integrin-dependent mechanism supports PI3K-independent chemotaxis stimulated by urokinase-type plasminogen activator. J. Cell Sci. 115:699-711. PMID: 11865026
52. Escudero-Esparza A, Jiang WG, Martin TA. (2012) Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways. J. Exp. Clin. Cancer Res. 31:43.
53. Shekarabi M, Moore SW, Tritsch NX, Morris SJ, Bouchard JF, Kennedy TE. (2005) Deleted in colorectal cancer binding netrin-1 mediates cell substrate adhesion and recruits Cdc42, Rac1, Pak1, and NWASP into an intracellular signaling complex that promotes growth cone expansion J. Neurosci. 25:3132-3141. PMID: 15788770
54. Le Clainche C, Schlaepfer D, Ferrari A, Klingauf M, Grohmanova K, Veligodskiy A, et al. (2007) IQGAP1 stimulates actin assembly through the N-WASP-Arp2/3 pathway. J. Biol. Chem. 282:426-435. PMID: 17085436
55. Wong NC, Mueller BM, Barbas CF, Ruminski P, Quaranta V, Lin EC, et al. (1998) Alphav integrins mediate adhesion and migration of breast carcinoma cell lines. Clin. Exp. Metastasis. 16:50-61. PMID: 9502077
56. Plopper GE, Domanico SZ, Cirulli V, Kiosses WB, Quaranta V. (1998) Migration of breast epithelial cells on Laminin-5: differential role of integrins in normal and transformed cell types. Breast Cancer Res. Treat. 51:57-69. PMID: 9877029
57. Chen J, Baskerville C, Han Q, Pan ZK, Huang S. (2001) Alpha(v) integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells. J. Biol. Chem. 276:47901-47905. PMID: 11606583
58. Retta SF, Cassarà G, D'Amato M, Alessandro R, Pellegrino M, Degani S, et al. (2001) Cross talk between beta(1) and alpha(V) integrins: beta(1) affects beta(3) mRNA stability. Mol. Biol. Cell. 12:3126-3138. PMID: 11598197
59. Katoh D, Nagaharu K, Shimojo N, Hanamura N, Yamashita M, Kozuka Y, et al. (2013) Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of breast cancer cells. Oncogenesis. 2:e65. doi: 10.1038/oncsis.2013.27 PMID: 23958855
60. Galliher AJ, Schiemann WP. (2006) Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res. 8:R42. PMID: 16859511
61. Zhang H, Li Z, Viklund EK, Strömblad S. (2002) P21-activated kinase 4 interacts with integrin alpha v beta 5 and regulates alpha v beta 5-mediated cell migration. J. Cell Biol. 158:1287-1297. PMID: 12356872
62. Vijaya Kumar A, Salem Gassar E, Spillmann D, Stock C, Sen YP, Zhang T, et al. (2014) HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression. Int. J. Cancer 135:2579-2592. doi: 10.1002/ijc.28921 PMID: 24752740
63. Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, et al. (2010) miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ. 17:246-254. doi: 10.1038/cdd.2009.117 PMID: 19730444
64. Havaki S, Kouloukoussa M, Amawi K, Drosos Y, Arvanitis LD, Goutas N, et al. (2007) Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancer. Cancer Cell Int. 7:16. PMID: 17910753
65. Peddibhotla SS, Brinkmann BF, Kummer D, Tuncay H, Nakayama M, Adams RH, et al. (2013) Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling. Mol. Biol. Cell. 24:933-944. doi: 10.1091/mbc.E12-06-0481 PMID: 23389628
66. Thomas M, Felcht M, Kruse K, Kretschmer S, Deppermann C, Biesdorf A, et al. (2010) Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation. J. Biol. Chem. 285:23842-23849. doi: 10.1074/jbc.M109.097543 PMID: 20519501
67. Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prévost N, et al. (2009) An integrin alpha (v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat. Med. 15:1163-1169. doi: 10.1038/nm.2009 PMID: 19734908
68. Lee HH, Chang ZF. (2008) Regulation of RhoA-dependent ROCKII activation by Shp2. J. Cell Biol. 181:999-1012. doi: 10.1083/jcb.200710187 PMID: 18559669
69. Papalouka V, Arvanitis DA, Vafiadaki E, Mavroidis M, Papadodima SA, Spiliopoulou CA, et al. (2009) Muscle LIM protein interacts with cofilin 2 and regulates F-actin dynamics in cardiac and sk 1. Mol Cell Biol. 29:6046-58. doi: 10.1128/MCB.00654-09 PMID: 19752190
70. Akao Y, Iio A, Itoh T, Noguchi S, Itoh Y, Ohtsuki Y, et al. (2011) Microvesicle-mediated RNA Molecule Delivery System Using Monocytes/Macrophages. Mol. Ther. 19: 395-399. doi: 10.1038/mt.2010.254 PMID: 21102562
71. Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM. (2012) Delivering the promise of miRNA cancer therapeutics. Drug Discov. Today 18: 282-289. doi: 10.1016/j.drudis.2012.10.002 PMID: 23064097
72. Santos-Carballal B, Aaldering LJ, Ritzefeld M, Pereira S, Sewald N, Moerschbacher BM, et al. (2015) Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells. Sci Rep. 5:13567. doi: 10.1038/srep13567 PMID: 26324407